From danny91@tie.cl  Mon Jul 25 23:46:43 2005
Return-Path: <danny91@tie.cl>
Received: from mx1.FreeBSD.org (mx1.freebsd.org [216.136.204.125])
	by hub.freebsd.org (Postfix) with ESMTP id 6BE8016A41F;
	Mon, 25 Jul 2005 23:46:43 +0000 (GMT)
	(envelope-from danny91@tie.cl)
Received: from tie.cl (113-135-217.adsl.cust.tie.cl [200.113.135.217])
	by mx1.FreeBSD.org (Postfix) with ESMTP id 8420F43D45;
	Mon, 25 Jul 2005 23:46:20 +0000 (GMT)
	(envelope-from danny91@tie.cl)
Message-Id: <002401c59173$118da810$4f3ecc91@RMCZMI>
Date: Mon, 25 Jul 2005 15:52:13 -0800
From: "Freddie Larson" <danny91@tie.cl>
To: <davidn@freebsd.org>
Subject: BioTech News for this weeks watch

>Number:         84098
>Category:       junk
>Synopsis:       BioTech News for this weeks watch
>Confidential:   no
>Severity:       serious
>Priority:       medium
>Responsible:    linimon
>State:          closed
>Quarter:        
>Keywords:       
>Date-Required:  
>Class:          sw-bug
>Submitter-Id:   current-users
>Arrival-Date:   Mon Jul 25 23:50:23 GMT 2005
>Closed-Date:    Tue Jul 26 06:01:08 GMT 2005
>Last-Modified:  Tue Jul 26 06:01:08 GMT 2005
>Originator:     
>Release:        
>Organization:
>Environment:
>Description:
 This is a multi-part message in MIME format.
 
 ------=_NextPart_000_0021_01C59138.652ED010
 Content-Type: text/plain;
 	charset="iso-8859-1"
 Content-Transfer-Encoding: quoted-printable
 
 .. TUESDAY JULY 26 WATCH PSIV,  ST0CK IS FLYING!!  UP  0.21 (87.50%) on M0NDAY 
 .. RADAR ALERT ....RADAR ALERT.....RADAR ALERT.....RADAR ALERT
  
 
 Pacific Sunset Investments Inc.
 SYMB0L: PSiV
 CURRENT PRICE: .40     UP  0.21 (87.50%)
 5 DAY Projection:  $1.25
  
 THIS ST0CK WAS .24 0N FRIDAY JULY 22, 2005  (See Yahoo Finance)
  
 How many times have you heard about this????
 adverse drug reactions accounted for more than 2.2 million serious cases and over 100,000 deaths, 
  
 PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV
  
 A study published in the Journal of the American Medical Association reported that adverse drug reactions accounted for more than 2.2 million serious cases and over 100,000 deaths, making adverse drug reactions (ADRs) one of the leading causes of hospita lization and death in the United States. 
  
 Breaking News for Pacific Sunset Investments
  
 Pacific Sunset Investments Completes Gen ID Acquisition
 HUNTINGT0N BEACH, Calif.--(BUSINESS WIRE)--May 20, 2005--Pacific Sunset Investments, Inc. ("Pacific Sunset") (0TC:PSiV announced that it has completed its acquisition of Gen-ID Lab Services, LLC, a California limited liability corporation specializing in  Single Nucleotide Polymorphism analysis data. In addition, the board of directors of Pacific Sunset has appointed Douglas Freedman to its board of directors with experience in marketing. Additionally, the company has appointed Dr. Steve N. Slilaty, Ph.D ., to head an Advisory Board to assist the company with reviewing new alternatives in the "SNP" field of technology. 
  
 Gen ID will provide "SNP" (Single Nucleotide Polymorphism) analysis data. The results of SNP analysis provide physicians with a more enlightened choice of drugs and they will also be able to predict the effectiveness of the drugs for individual patients.  The use of an SNP test to help treat childhood leukemia is currently being used by doctors and hospitals in the United States. 
  
 Dr. Steve Slilaty is President and Chief Scientific 0fficer of Advanomics Corporation, a leading-edge biotechnology company focusing on the identification of disease related molecular targets using advanced transriptomics technologies, which he recently  developed. Dr. Slilaty also is an Adjunct Professor at the Universite du Quebec in the department of Microbiology and Biotechnology. Dr. Slilaty has founded three biotechnology companies, Advanomics Corporation, Quantum Biotechnologies Inc. (now known as  Qbiogene Inc.) and Geneomics 0ne Corporation. In addition, Dr. Slilaty is one of the pioneers of Gene Therapy, having developed the first Gene Transfer system in 1983. 
  
 (This is a partial clip of the news.  We suggest you go read the whole release.  0ur opinion is, this is important technology.  Go to yahoo or any financial site and read the news)
  
 C0NCLUSI0N:
 adverse drug reactions accounted for more than 2.2 million serious cases and over 100,000 deaths,  Doesn't this say it all? 
  
  A company to watch!
  
 AGGRESSIVE INVEST0RS TAKE N0TE N0W! 
 PUT Pacific Sunset Investments Inc. PSiV
 0N Y0UR RADAR SCREENS N0W,
 AND WATCH THIS C0MPANY STARTING N0W
  
 IF Y0U ARE
 RECEIVING THIS EMAIL, Y0U ARE AM0NG THE FIRST PUBLIC INVEST0RS T0 KN0W AB0UT
 PSiV !!!!
  
 
 Disclaimer: 
 Information within this email contains "forwardlooking statements" within 
 the meaning of Section 27Aof the Securities Act of 1933 and Section 21B of 
 the Securities Exchange Act of 1934. Any statements that express or involve 
 discussions with respect to predictions, expectations, beliefs, 
 plans, projections, objectives, goals, assumptions or future events or 
 performance are not statements of historical fact and may be "forward 
 looking statements". "Forward looking statements" are based on 
 expectations, estimates and projections at the time the statements are made 
 that involve a number of risks and uncertainties which could cause actual 
 results or events to differ materially from those presently anticipated. 
 Forward looking statements in this action may be identified through the use 
 of words such as "projects", "foresee", "expects", "will", "anticipates", 
 "estimates", "believes", "understands" or that by statements indicating 
 certain actions "may", "could", or "might" occur. Risk factors include 
 general economic and business conditions, the ability to acquire and develop 
 specific projects, the ability to fund operations and changes in consumer 
 and business consumption habits and other factors overwhich the company has 
 little or no control. The publisher of this newsletter does not represent 
 that the information contained in this message states all material facts or 
 does not omit a material fact necessary to make the statements therein not 
 misleading. All information provided within this email pertaining to 
 investing, ST0CKs, securities must be understood as information provided and 
 not investment advice. The publisher of this newsletter advises all readers 
 and subscribers to seek advice from a registered professional securities 
 representative before deciding to trade in ST0CKs featured within this 
 email. None of the material within this report shall be construed as any 
 kind of investment advice or solicitation. Many of these companies are on 
 the verge of bankruptcy. You can lose all your money by investing in this 
 ST0CK. We urge you to read the company's SEC filings now, before you invest. 
 The publisher of this newsletter is not a registered invstment advisor. 
 Subscribers should not view information herein as legal, tax, accounting or 
 investment advice. In compliance with the SecuritiesAct of 1933, Section 
 17(b), The publisher of this newsletter is contracted to receive two hundred  
 thousand free trading shares from a third party, not an officer, director or 
 affiliate shareholder for the circulation of this report. Be aware of an 
 inherent conflict of interest resulting from such compensation due to the 
 fact that this is a paid advertisement and is not without bias. The party 
 that paid us has a position in the ST0CK they will sell at anytime without 
 notice. This could have a negative impact on the price of the ST0CK, causing 
 you to lose money. All factual information in this report was gathered from 
 public sources, including but not limited to SEC filings, Company Websites 
 and Company Press Releases. The publisher of this newsletter believes this 
 information to be reliable but can make no guarantee as to its accuracy or 
 completeness. Use of the material within this email constitutes your 
 acceptance of these terms
 ------=_NextPart_000_0021_01C59138.652ED010
 Content-Type: text/html;
 	charset="iso-8859-1"
 Content-Transfer-Encoding: quoted-printable
 
 <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
 <HTML><HEAD>
 <META http-equiv=Content-Type content="text/html; charset=iso-8859-1">
 <META content="MSHTML 6.00.2800.1498" name=GENERATOR>
 <STYLE></STYLE>
 </HEAD>
 <BODY bgColor=#ffffff>
 <DIV><FONT face=Arial size=2>.. TUESDAY JULY 26 WATCH PSIV,&nbsp; ST0CK IS 
 FLYING!!&nbsp; UP&nbsp; 0.21 (87.50%) on M0NDAY <BR>.. RADAR ALERT .....RADAR 
 ALERT.....RADAR ALERT.....RADAR ALERT<BR>&nbsp;</FONT></DIV>
 <DIV>&nbsp;</DIV>
 <DIV><FONT face=Arial size=2>Pacific Sunset Investments Inc.<BR>SYMB0L: 
 PSiV<BR>CURRENT PRICE: .40&nbsp;&nbsp;&nbsp;&nbsp; UP&nbsp; 0.21 (87.50%)<BR>5 
 DAY Projection:&nbsp; $1.25<BR>&nbsp;<BR>THIS ST0CK WAS .24 0N FRIDAY JULY 22, 
 2005&nbsp; (See Yahoo Finance)<BR>&nbsp;<BR>How many times have you heard about 
 this????<BR>adverse drug reactions accounted for more than 2.2 million serious 
 cases and over 100,000 deaths, 
 <BR>&nbsp;<BR>PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV<BR>&nbsp;<BR>A 
 study published in the Journal of the American Medical Association reported that 
 adverse drug reactions accounted for more than 2.2 million serious cases and 
 over 100,000 deaths, making adverse drug reactions (ADRs) one of the leading 
 causes of hospitalization and death in the United States. <BR>&nbsp;<BR>Breaking 
 News for Pacific Sunset Investments<BR>&nbsp;<BR>Pacific Sunset Investments 
 Completes Gen ID Acquisition<BR>HUNTINGT0N BEACH, Calif.--(BUSINESS WIRE)--May 
 20, 2005--Pacific Sunset Investments, Inc. ("Pacific Sunset") (0TC:PSiV 
 announced that it has completed its acquisition of Gen-ID Lab Services, LLC, a 
 California limited liability corporation specializing in Single Nucleotide 
 Polymorphism analysis data. In addition, the board of directors of Pacific 
 Sunset has appointed Douglas Freedman to its board of directors with experience 
 in marketing. Additionally, the company has appointed Dr. Steve N. Slilaty, 
 Ph.D., to head an Advisory Board to assist the company with reviewing new 
 alternatives in the "SNP" field of technology. <BR>&nbsp;<BR>Gen ID will provide 
 "SNP" (Single Nucleotide Polymorphism) analysis data. The results of SNP 
 analysis provide physicians with a more enlightened choice of drugs and they 
 will also be able to predict the effectiveness of the drugs for individual 
 patients. The use of an SNP test to help treat childhood leukemia is currently 
 being used by doctors and hospitals in the United States. <BR>&nbsp;<BR>Dr. 
 Steve Slilaty is President and Chief Scientific 0fficer of Advanomics 
 Corporation, a leading-edge biotechnology company focusing on the identification 
 of disease related molecular targets using advanced transriptomics technologies, 
 which he recently developed. Dr. Slilaty also is an Adjunct Professor at the 
 Universite du Quebec in the department of Microbiology and Biotechnology. Dr. 
 Slilaty has founded three biotechnology companies, Advanomics Corporation, 
 Quantum Biotechnologies Inc. (now known as Qbiogene Inc.) and Geneomics 0ne 
 Corporation. In addition, Dr. Slilaty is one of the pioneers of Gene Therapy, 
 having developed the first Gene Transfer system in 1983. <BR>&nbsp;<BR>(This is 
 a partial clip of the news.&nbsp; We suggest you go read the whole 
 release.&nbsp; 0ur opinion is, this is important technology.&nbsp; Go to yahoo 
 or any financial site and read the news)<BR>&nbsp;<BR>C0NCLUSI0N:<BR>adverse 
 drug reactions accounted for more than 2.2 million serious cases and over 
 100,000 deaths,&nbsp; Doesn't this say it all? <BR>&nbsp;<BR>&nbsp;A company to 
 watch!<BR>&nbsp;<BR>AGGRESSIVE INVEST0RS TAKE N0TE N0W! <BR>PUT Pacific Sunset 
 Investments Inc. PSiV<BR>0N Y0UR RADAR SCREENS N0W,<BR>AND WATCH THIS C0MPANY 
 STARTING N0W<BR>&nbsp;<BR>IF Y0U ARE<BR>RECEIVING THIS EMAIL, Y0U ARE AM0NG THE 
 FIRST PUBLIC INVEST0RS T0 KN0W AB0UT<BR>PSiV !!!!<BR>&nbsp;</FONT></DIV>
 <DIV>&nbsp;</DIV>
 <DIV><FONT face=Arial size=2>Disclaimer: <BR>Information within this email 
 contains "forwardlooking statements" within <BR>the meaning of Section 27Aof the 
 Securities Act of 1933 and Section 21B of <BR>the Securities Exchange Act of 
 1934. Any statements that express or involve <BR>discussions with respect to 
 predictions, expectations, beliefs, <BR>plans, projections, objectives, goals, 
 assumptions or future events or <BR>performance are not statements of historical 
 fact and may be "forward <BR>looking statements". "Forward looking statements" 
 are based on <BR>expectations, estimates and projections at the time the 
 statements are made <BR>that involve a number of risks and uncertainties which 
 could cause actual <BR>results or events to differ materially from those 
 presently anticipated. <BR>Forward looking statements in this action may be 
 identified through the use <BR>of words such as "projects", "foresee", 
 "expects", "will", "anticipates", <BR>"estimates", "believes", "understands" or 
 that by statements indicating <BR>certain actions "may", "could", or "might" 
 occur. Risk factors include <BR>general economic and business conditions, the 
 ability to acquire and develop <BR>specific projects, the ability to fund 
 operations and changes in consumer <BR>and business consumption habits and other 
 factors overwhich the company has <BR>little or no control. The publisher of 
 this newsletter does not represent <BR>that the information contained in this 
 message states all material facts or <BR>does not omit a material fact necessary 
 to make the statements therein not <BR>misleading. All information provided 
 within this email pertaining to <BR>investing, ST0CKs, securities must be 
 understood as information provided and <BR>not investment advice. The publisher 
 of this newsletter advises all readers <BR>and subscribers to seek advice from a 
 registered professional securities <BR>representative before deciding to trade 
 in ST0CKs featured within this <BR>email. None of the material within this 
 report shall be construed as any <BR>kind of investment advice or solicitation. 
 Many of these companies are on <BR>the verge of bankruptcy. You can lose all 
 your money by investing in this <BR>ST0CK. We urge you to read the company's SEC 
 filings now, before you invest. <BR>The publisher of this newsletter is not a 
 registered invstment advisor. <BR>Subscribers should not view information herein 
 as legal, tax, accounting or <BR>investment advice. In compliance with the 
 SecuritiesAct of 1933, Section <BR>17(b), The publisher of this newsletter is 
 contracted to receive two hundred&nbsp; <BR>thousand free trading shares from a 
 third party, not an officer, director or <BR>affiliate shareholder for the 
 circulation of this report. Be aware of an <BR>inherent conflict of interest 
 resulting from such compensation due to the <BR>fact that this is a paid 
 advertisement and is not without bias. The party <BR>that paid us has a position 
 in the ST0CK they will sell at anytime without <BR>notice. This could have a 
 negative impact on the price of the ST0CK, causing <BR>you to lose money. All 
 factual information in this report was gathered from <BR>public sources, 
 including but not limited to SEC filings, Company Websites <BR>and Company Press 
 Releases. The publisher of this newsletter believes this <BR>information to be 
 reliable but can make no guarantee as to its accuracy or <BR>completeness. Use 
 of the material within this email constitutes your <BR>acceptance of these 
 terms</FONT></DIV></BODY></HTML>
 
 ------=_NextPart_000_0021_01C59138.652ED010--
>How-To-Repeat:
>Fix:
>Release-Note:
>Audit-Trail:
State-Changed-From-To: open->closed 
State-Changed-By: linimon 
State-Changed-When: Tue Jul 26 06:00:45 GMT 2005 
State-Changed-Why:  
spam 


Responsible-Changed-From-To: gnats-admin->linimon 
Responsible-Changed-By: linimon 
Responsible-Changed-When: Tue Jul 26 06:00:45 GMT 2005 
Responsible-Changed-Why:  

http://www.freebsd.org/cgi/query-pr.cgi?pr=84098 
>Unformatted:
